Sarcoidosis: all 285 studies

Page 3 of 3. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• RCT Comparing 21 and 22 G Needle in the Diagnosis of Sarcoidosis by EBUS TBNACompletedNCT02459431Not applicable
• A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With SarcoidosisCompletedNCT02405897Not applicable
• Validation of a Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled BreathStatus unknownNCT02361281
• Use of Immunosuppressive Therapy for SarcoidosisStatus unknownNCT02356445
• ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label TrialStatus unknownNCT02348905Phase 2/3
• Inspiratory Muscle Training in SarcoidosisCompletedNCT02270333Not applicable
• Fractionated Versus Target-controlled Propofol Administration in BronchoscopyCompletedNCT02246023Phase 4
• Physical Training in Sarcoidosis PatientsCompletedNCT02243995Not applicable
• Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).CompletedNCT02200146Phase 3
• A Phase 2 Study With CC-220 in Skin SarcoidosisWithdrawnNCT02192489Phase 2
• Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)Status unknownNCT02188017Phase 4
• Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.TerminatedNCT02168036
• ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot StudyStatus unknownNCT02155803Phase 2/3
• Labial Biopsy in Patients With Tuberculosis DiseaseCompletedNCT02115854
• Pulmonary Rehabilitation in Patients With SarcoidosisCompletedNCT02044939Not applicable
• A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible BronchoscopyCompletedNCT01955824Phase 2/3
• Low-dose Dexamethasone in Newly Diagnosed Pulmonary SarcoidosisStatus unknownNCT01920919Phase 3
• A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of SarcoidosisCompletedNCT01908868Not applicable
• Development of a Novel Human In Vitro Sarcoidosis ModelCompletedNCT01857401
• Bronchoscopic Sampling Techniques in SarcoidosisStatus unknownNCT01836822Not applicable
• Genomic Research in SarcoidosisCompletedNCT01831739
• Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)Status unknownNCT01830959Phase 4
• Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.Status unknownNCT01809145Not applicable
• Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal SamplingStatus unknownNCT01784185Not applicable
• 18F-FDG PET Imaging in Cardiac SarcoidosisApproved for marketingNCT01764191
• Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PETCompletedNCT01729169
• Efficacy and Safety of Influenza Vaccine During SarcoidosisCompletedNCT01687517Phase 3
• Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal LymphadenopathiesCompletedNCT01658280Phase 4
• Treatment of Renal Sarcoidosis by Methylprednisolone BolusTerminatedNCT01652417Not applicable
• Perfusion Analysis Using Rubidium in Cardiac SarcoidosisCompletedNCT01648933Not applicable
• Worldwide Sarcoidosis Research StudyCompletedNCT01610843
• Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)Status unknownNCT01467791
• EBUS-TBNA Versus EBUS-TBNBWithdrawnNCT01467635Not applicable
• Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary SarcoidosisTerminatedNCT01440192Phase 1
• Rehabilitation in Pulmonary Sarcoidosis: a Prospective StudyStatus unknownNCT01384123
• Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)CompletedNCT01361139
• Efficacy of Antituberculous Therapy in Management of SarcoidosisCompletedNCT01245036Not applicable
• Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityTerminatedNCT01241942Not applicable
• Cardiac Sarcoidosis Response To Steroids TrialWithdrawnNCT01210677Phase 4
• Sarcoidosis-associated Pulmonary HypertensionCompletedNCT01139710
• Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac SarcoidosisCompletedNCT01013311
• Cardiac Sarcoidosis and FDG-PETCompletedNCT00958087
• A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)Status unknownNCT00932854Not applicable
• Safety and Efficacy Study of Bosentan in Progressive Pulmonary SarcoidosisTerminatedNCT00926627Phase 2
• Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal AdenopathyCompletedNCT00915330Not applicable
• Minimally Invasive Techniques Or Surgery In the Diagnosis of SarcoidosisCompletedNCT00888212Not applicable
• Trial for the Diagnosis of SarcoidosisCompletedNCT00872612Phase 3
• Rituximab for Pulmonary SarcoidosisCompletedNCT00855205Phase 2
• Muscle Strength and Exercise Capacity in Sarcoidosis PatientsCompletedNCT00854672
• Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT00851929Phase 2/3
• Stromal Gene Expression During Pulmonary SarcoidosisTerminatedNCT00837668
• Antibody Response to Influenza Vaccine in Patients With SarcoidosisCompletedNCT00828828
• The Efficacy and Safety of CC-10004 in Chronic Cutaneous SarcoidosisCompletedNCT00794274Phase 2/3
• CryoSpray Ablation(tm)Thoracic Patient RegistryWithdrawnNCT00785239
• Efficacy Study of Humira in the Treatment of Cutaneous SarcoidosisWithdrawnNCT00731757Phase 2
• Study of Nicotine Patches in Patients With SarcoidosisCompletedNCT00701207Early Phase 1
• Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous SarcoidosisWithdrawnNCT00690911Phase 2
• Role of Proteomics in Diagnosing SarcoidosisCompletedNCT00626938
• Diagnostic Yield of Vitreous Biopsy in Sarcoid UveitisCompletedNCT00609687Not applicable
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT00581607Phase 2/3
• Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and SarcoidosisCompletedNCT00560989
• Use of Armodafinil for Fatigue in SarcoidosisCompletedNCT00555347Phase 2/3
• The Occurence of Inflammation and Oxidative Stress in Lung DiseasesCompletedNCT00512967
• The Influence of Personality on Pulmonary Fibrosis and SarcoidosisCompletedNCT00504621
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
• The Effect of Quercetin in SarcoidosisCompletedNCT00402623Not applicable
• Eye and Immunogenetic Features of SarcoidosisCompletedNCT00379275
• Endobronchial Ultrasonography in the Diagnosis of SarcoidosisCompletedNCT00373555Not applicable
• Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis PatientCompletedNCT00369980
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesCompletedNCT00366509
• Use of Focalin for Fatigue in SarcoidosisCompletedNCT00361387Phase 4
• Rickettsial Genesis to Sarcoidosis in DenmarkCompletedNCT00326534
• SARCOTHAL. Thalidomide in Skin SarcoidosisCompletedNCT00305552Phase 3
• A Study of Adalimumab to Treat Sarcoidosis of the SkinCompletedNCT00274352Phase 2
• Mycophenolate for Pulmonary SarcoidosisTerminatedNCT00262132Phase 3
• Pathogen Specific Immunity in Patients With SarcoidosisCompletedNCT00217789
• Salivary Proteins in Disease and HealthCompletedNCT00100204
• Exercise Training in Sarcoidosis (EXTRAS Study)CompletedNCT00099424Not applicable
• A Study of Infliximab in Patients With SarcoidosisCompletedNCT00073437Phase 3
• Sarcoid Genetic Analysis (SAGA)CompletedNCT00005542
• Genetic Epidemiology of SarcoidosisCompletedNCT00005531
• A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)CompletedNCT00005276
• Treatment of Pulmonary Sarcoidosis With PentoxifyllineCompletedNCT00001877Phase 2
• Study of Eye Tissue for SarcoidosisCompletedNCT00001278
• Diffuse Fibrotic Lung DiseaseCompletedNCT00000596Phase 2

← Sarcoidosis overview